Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?

Key Points

• Astera Labs reported Q3 revenue growth of 153.6% to $584.9 million and adjusted EPS of $1.32, both topping analyst estimates on strong Scorpio product demand.
• Despite the strong results and bullish Q4 guidance, analysts trimmed price targets citing valuation concerns, though most maintained a long-term bullish outlook on the stock.
• Institutional investors own more than 60% of shares and have consistently accumulated the stock since its IPO, reflecting confidence in Astera Labs' market position.

Price action triggered by Astera Labs’ NASDAQ: ALAB Q3 earnings release isn’t all that surprising, given the response to other reports and signals reflected across the tech landscape.hearthear

As strong as the Q3 results were, they merely reaffirmed what the market already knows: the AI trade is maturing.

Doubt and fear that the AI build won't continue, compounded by high valuations, are in play, but an opportunity has emerged.

Together, they are pushing stock prices down and creating a deep-value opportunity in the winning stocks.

As the AI trade matures, investors are shifting from broad speculation about AI's potential and its eventual winners, which helped lift much of the technology sector, toward a smaller group of companies delivering tangible results.

These companies, like Astera Labs, are securing design wins that can support revenue over multiple years, providing the nuts and bolts to build giant AI computers. The bad news, or rather, the opportunity, is that the good companies are being punished along with the bad, but that will likely change over the coming quarters, driven by performance.

The technical charts for Astera Labs and Credo Technology Group NASDAQ: CRDO, another connectivity leader, suggest that both stocks have completed or are nearing the end of an Elliott Wave cycle, presenting two possible scenarios.

The first is that the AI boom and bust is over, and ALAB, along with CRDO, are down for the count. The other is that the AI build continues, results align with the growth outlook, and market sentiment recovers. In that scenario, the first Elliott Wave Cycle becomes the first stage in a much larger cycle that can take this market to new highs before the end of next year.

Astera Labs' Q3 Earnings Show AI Demand Is Still Accelerating

Astera Labs Q3 results echo the message in reports from Advanced Micro Devices NASDAQ: AMD, onsemi NASDAQ: ON, Oracle NASDAQ: ORCL, andNXP Semiconductors NASDAQ: NXPI, to mention a few.

That is, AI demand is strong, broad-based, and accelerating, driven by ramping production of next-gen products. Astera Labs’ revenue grew by 153.6% to $584.9 million, exceeding the $550.8 million analyst consensus estimate, driven by strength in the Scorpio line. Scorpio is the newest and now largest product family, smart fabric switches essential to linking massive GPU clusters into an efficient, cohesive operating unit.

Astera Labs’ margin news was what the market wanted, revealing strong revenue and scale leverage. While gross margin compressed, operating efficiency and spending control shone through, with GAAP operating income rising to $179.1 million from $55.4 million a year earlier and adjusted net income climbing to $243.4 million from $88.2 million.

On the bottom line, $1.32 in adjusted earnings per share (EPS) is also up more than 100% and outperformed the analyst consensus by more than 10%, playing into management’s decision to issue hot guidance.

Guidance is bullish for this market, regardless of the stock price response to the news. Management expects Q4 revenue of $730 million to $750 million and adjusted EPS of $1.62 to $1.66, with the low ends of both ranges exceeding analyst expectations. The outlook may also prove conservative, given the company's competitive advantages, particularly its Scorpio product line.

Astera Labs has established an early lead in high-volume PCIe Gen 6 switching, with Scorpio production and a lever for exponential growth: multiple design wins across numerous customers and end markets.

It is important that investors understand the difference between design wins and sales. Unlike an immediate sale, a design win can create a multi-year revenue opportunity as customers incorporate Astera Labs' technology into their products and expand production. Some of these programs could generate substantial incremental revenue as they scale.

As Astera's largest and fastest-growing line, Scorpio has already topped a $1 billion run-rate and is likely to accelerate in the coming year.

Analysts Deflate Outlook, But Maintain Bullish Stance

Analysts' responses to the news highlight the near-term valuation headwind and long-term opportunity.

While most reduced their price targets, analysts generally maintained a bullish long-term outlook, citing valuation concerns and broader market conditions as reasons to limit near-term expectations.

The average analyst price target currently implies around 68% upside and is up approximately 77% over the past year.

Institutional activity also reflects a bullish posture. The group owns more than 60% of the shares and has bought on balance every quarter since the IPO through early Q4 2026.

The risk is that they shed shares and add momentum to the downturn; the company's strong market position, profitability, and history of institutional accumulation could help limit that risk. Profitability is a primary factor in the ongoing market-wide shift; companies that aren’t profitable and lack revenue will likely be left behind in the subsequent recovery, while stocks like ALAB are positioned to lead.